长春高新：第十一届董事会第十五次会议决议公告

Group 1 - The core point of the article is that Changchun High-tech has announced the approval of a unique licensing agreement for the GenSci098 injection project by its 11th Board of Directors during the 15th meeting [2] Group 2 - The announcement was made on the evening of December 15 [2] - The decision reflects the company's strategic move to enhance its product offerings through collaboration [2] - The licensing agreement is expected to contribute positively to the company's future revenue streams [2]